Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neuroendocrine Tumors 5Neuroblastoma 2Medulloblastoma 2Carcinoma, Neuroendocrine 2von Hippel-Lindau Disease 1Tumor Positron-Emission Tomography 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Prostatic Neoplasms 1Parathyroid Neoplasms 1Multiple Endocrine Neoplasia 1Meningioma 1Hypoglycemia 1Hyperparathyroidism 1Hypercalcemia 1Carcinoid Tumor 1Cancer Diagnosis 1

Interventions

gallium Ga 68 dotatate 168Ga-FAPI 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tumor Positron-Emission Tomography × gallium Ga 68 dotatate × Clear all
NCT05990998 2024-02-26

A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study

First Affiliated Hospital of Fujian Medical University

Phase 1/2 Completed
38 enrolled

Tumor Positron-Emission Tomography

Data powered by HemOnc (CC BY 4.0) Colophon âš¡